Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine D... ( ROCKVILLE Md. May 22 /- Novavax I...)

Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development

Date:5/22/2008

ROCKVILLE, Md., May 22 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it has created a new proprietary process to develop a vaccine candidate against Severe Acute Respiratory Syndrome (SARS). The company also received renewed research funding from the National Institutes of Health (NIH) to continue preclinical development of SARS vaccine candidates using Novavax's virus-like particle (VLP) technology.

"Until now, it has been difficult to produce VLP vaccine candidates against SARS and other complex infectious disease targets because many of these biological structures do not assemble efficiently," said Dr. Gale Smith, Vice President, Vaccine Development. "Our new proprietary process uses select components of SARS and other structural proteins that combine with cell membranes to form distinctive SARS coronavirus nanoparticles, which are nearly identical to the human SARS virus but lack the genetic material needed to replicate and cause disease."

"This new approach to create VLPs will allow us to continue our work to develop a SARS vaccine candidate and expand the potential applications of our vaccine technology to a broad range of infectious diseases around the world," said Rahul Singhvi, President and Chief Executive Officer of Novavax, Inc.

Severe acute respiratory syndrome (SARS) is a viral respiratory illness caused by a coronavirus and was first reported in Asia in February 2003. According to the World Health Organization (WHO), subsequent to the 2003 breakout, over 8,000 people were infected, with 774 reported deaths. While there is currently no known reported SARS transmission globally, WHO and other such agencies continue to monitor the SARS situation on a global basis as health officials remain concerned that SARS or similar disease could reemerge.

The SARS VLP program is conducted under an NIH grant. Novavax does not have the commercial rights to this product candidate.

About Novavax '/>"/>

SOURCE Novavax, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial
2. Novavax Reports Positive Results from Preclinical Studies of its VLP-based Trivalent Seasonal Influenza Vaccine Candidate
3. Novavax Reports Fourth Quarter and 2007 Year-End Financial Results
4. Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program
5. Novavax Announces Preclinical Results for Seasonal Influenza Vaccine Program
6. GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution
7. Novavax Reports Third Quarter 2007 Financial Results and Progress with Vaccine Development Programs
8. Novavax CEO to Present at ACUMENBioFins 9th Annual Healthcare Conference
9. BARC Announces Long-Term Cooperation In South African Biobanking for HIV Vaccine Trials
10. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
11. QuatRx Pharmaceuticals Announces Presentation of Further Data from Ophena(TM) (Ospemifene) Phase 3 Study for Treatment of Symptoms of Vulvovaginal Atrophy

Post Your Comments:

(Date:5/23/2013)... 23, 2013 The need to add tissue ... was highlighted prominently at the 108 th ... in San Diego. According to SonaCare Medical, a ... (HIFU) technology, the need for image-guided technologies to ... to consider minimally invasive ablative treatments, was addressed ...

(Date:5/23/2013)... -- Texas, premier physician associations today announced the establishment of ... need to provide demonstrably better and more efficient patient ... "I am confident the Physician Services Organization for ... Stephen L. Brotherton , MD, president of the ... doctors are determined to make health care better and ...

(Date:5/23/2013)... May 23, 2013 Direct to implant, ... is an appropriate option for many women with ... reduce their breast cancer risk, or with breast ... process and a second surgery to insert permanent ... same surgery as mastectomy can be a medically ...

Breaking Medicine Technology:Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 2 Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 3 Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 4 Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 5 Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 6 TMA Launches Physician Services Organization for Patient Care 2 TMA Launches Physician Services Organization for Patient Care 3 TMA Launches Physician Services Organization for Patient Care 4 Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 2 Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 3

[0] Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting [0] TMA Launches Physician Services Organization for Patient Care [0] Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results

... LAUDERDALE, Fla., Sept. 23 OmniComm Systems, Inc. ... in the EDC marketplace, today announced that Beardsworth, ... specializes in difficult therapeutic areas, has selected OmniComm,s ... process. AE Reporting is an advanced adverse event ...

... According to Millennium Research Group (MRG), the ... physicians will increasingly adopt abdominal and thoracic endovascular aortic ... awareness of the benefits of endovascular techniques grows and ... tends to be a slightly more attractive option for ...

Cached Medicine Technology:Beardsworth® Selects OmniComm Systems® AE Reporting System 2 Beardsworth® Selects OmniComm Systems® AE Reporting System 3 Latin American Aortic Stent Graft Market to Reach Over $150 Million by 2015, According to Millennium Research Group 2

Beardsworth® Selects OmniComm Systems® AE Reporting System Latin American Aortic Stent Graft Market to Reach Over $150 Million by 2015, According to Millennium Research Group

(Date:5/24/2013)... used to treat glaucoma may cause droopy eyelids and ... to a new study. The drugs, known as ... pressure, have already been shown to cause blurred vision, ... suggesting that the new findings could lead to labeling ... when prescribing these drugs, the researchers added, particularly as ...

(Date:5/24/2013)... to replicate what appeared to be breakthrough results for ... published last year in the journal Science . ... that the drug bexarotene (marketed as Targretin) could rapidly ... a pathological hallmark of Alzheimer,s disease in the ... 2012 report, drug treatment quickly removed most of the ...

(Date:5/24/2013)... 2013 The nation’s first trial of ... Inc.’s da Vinci Surgical System concluded yesterday, Bernstein Liebhard ... State Court jury ruled in a 10-to-2 decision that ... who performed a da Vinci prostatectomy on a patient ... had alleged in their lawsuit that the da Vinci ...

(Date:5/24/2013)... New York, NY (PRWEB) May 24, 2013 ... of Yahoo Commerce VP, Brandon Huff as Executive Vice ... ran its commerce business units, which represented a large ... will lead digital growth as Dwell develops a fully-integrated ... him a decade of experience monetizing digital content for ...

(Date:5/24/2013)... May 24 (HealthDay News) -- People with high levels ... to die of liver disease than those with lower ... of cadmium in urine is evidence of long-term exposure ... pollution and tobacco smoke, the Johns Hopkins researchers explained. ... that cadmium directly causes liver disease but instead suggest ...

Breaking Medicine News(10 mins):Health News:Common Glaucoma Drug May Cause Droopy Eyelids, Study Finds 2 Health News:Multiple research teams unable to confirm high-profile Alzheimer's study 2 Health News:Multiple research teams unable to confirm high-profile Alzheimer's study 3 Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on Verdict in Nation’s First Trial Involving Alleged Da Vinci Complications 2 Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on Verdict in Nation’s First Trial Involving Alleged Da Vinci Complications 3 Health News:Yahoo Commerce Head Joins Leadership at Dwell Media 2 Health News:High Cadmium Levels May Raise Risk for Dying From Liver Disease: Study 2

[0] Common Glaucoma Drug May Cause Droopy Eyelids, Study Finds [0] Multiple research teams unable to confirm high-profile Alzheimer's study [0] Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on Verdict in Nation’s First Trial Involving Alleged Da Vinci Complications [0] Yahoo Commerce Head Joins Leadership at Dwell Media [0] High Cadmium Levels May Raise Risk for Dying From Liver Disease: Study

... , NEW YORK, Sept. ... research report is available in its catalogue. , ... Opportunities Post-Launch: Contract Manufacturing and Contract Sales and ... http://www.reportlinker.com/p099450/Pharmaceutical-Outsourcing-Opportunities-Post-Launch-Contract-Manufacturing-and-Contract-Sales-and-Marketing-3rd-Edition.html , , ...

... NEW YORK, Sept. 22 Reportlinker.com announces that a new market research ... Medical Beds and Medical Chairs , , ... , This report provides the reader with an overview ... growth. Medical beds include all hospital types of beds including mattresses and ...

... , , , , ... released the "100 Best Companies for Working Mothers" list and this marks ... , , "SC Johnson is pleased to be honored ... of SC Johnson. "Treating our people with respect, integrity and fairness is ...

... , PETERSBURG, Va., Sept. 22 ... of low-nitrosamine smokeless tobacco products, announced today that the company ... preparation of tobacco to formulate dissolvable smokeless tobacco products. This ... filed in December, 2008. Its use has resulted in tobacco ...

... RICHMOND, Va., Sept. 22 Defying expectations in this time ... among the Top Ten 2009 Working Mother 100 Best Companies ... named to Working Mother ,s prestigious list consecutively since 1999, earning ... , , "Being recognized as a Top Ten employer ...

... ... iPhone™ Application Developed by Dr. Richard Bandler , ... Köping, Sweden (Vocus) — Hästens, the luxury bed maker ... for the iPhone™ and iPod Touch™, the most recent technological extension of the company’s ...

Reportlinker Adds Pharmaceutical Outsourcing Opportunities Post-Launch: Contract Manufacturing and Contract Sales and Marketing, 3rd Edition Report Reportlinker Adds Medical Beds and Medical Chairs Report SC Johnson a Best Company for Working Moms Star Scientific Breaks New Ground, Plans FDA Filing for Approval of First 'Modified Risk' Tobacco Product; Nominates Curtis Wright, MD, MPH for FDA Advisory Committee Bon Secours Richmond Named A Top Ten 2009 Working Mother 100 Best Company Luxury Bed Maker Hstens Introduces Mindspa iPhone™ Application

SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...

Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...

Medicine Products:

Reddick/Saye Needle Holder, Straight Reddick/Saye Needle Holder, Curved Left MultAcoice™ Biopsy Forceps with Teeth MultAcoice™ Grasping Forceps 2x3 Teeth